Satish Srinivasan

Satish Srinivasan is the current CEO at DiRx Health. Satish has over 20 years of experience in the pharmaceutical industry, with a focus on sterile generic and specialty pharmaceutical products.

Srinivasan began their career at Sentiss Pharma Pvt. Ltd., where they served as President - North America from May 2018 to March 2020. During their time at Sentiss, they were responsible for the company's expansion into the North American market.

In July 2013, Srinivasan joined Rising Pharmaceuticals, Inc. as President & COO. During their 3.5 year tenure at Rising, they led a team that resulted in a 3X revenue growth within 3 years, making it a $200M business. In December 2016, Srinivasan transitioned out of their leadership role at Rising after the company's $412M acquisition of the assets of Citron Pharmaceuticals, Inc.

Srinivasan has a proven track record of success in the pharmaceutical industry, and they are currently using their skills and experience to lead DiRx Health to success.

Satish Srinivasan has a Master's degree in Pharmacy Administration from the University of Illinois Chicago and a Bachelor's degree in Pharmaceutical Sciences from the University of Mumbai. Satish also attended Asan Memorial School.

Some direct reports include Nagy Shagrithaya - Chief Business Officer, Dimitrios Angelis - General Counsel, and Simone Grapini-Goodman - Chief Marketing Officer.